Ryan Cooley, MD
Clinical Cardiac Electrophysiology · St. George, UTNPI 1255308813
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (31.9%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Medtronic at 51.1% of the total. Reporting peaked in 2021 at $6,426 and has fallen 60.2% since, to $2,555 in 2025. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in UT, where the typical reported total is $33,716.
Across 148 payments — averaging $111.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$8K
- Biotronik Inc.$3K
- Cvrx, Inc.$1K
- Abbott$979
- Boston Scientific$931
- Biosense Webster, Inc.$646
- plus $691 from 11 others
Across 1 payment — averaging $2700.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- H. Lundbeck A S$3K
What the payments were for
- Consulting fees$5,25032%
- Speaking & faculty fees$1,2007%
- Travel & lodging$4,91330%
- Food & beverage$5,09631%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 50 | $8,408 |
| Biotronik Inc. | 17 | $3,394 |
| Cvrx, Inc. | 9 | $1,410 |
| Abbott | 8 | $979 |
| Boston Scientific | 16 | $931 |
| Biosense Webster, Inc. | 16 | $646 |
| Novartis | 9 | $168 |
| Johnson & Johnson | 9 | $135 |
| Tactile Systems Technology Inc | 1 | $85 |
| Atricure, Inc. | 2 | $80 |
| Cardiofocus, Inc. | 1 | $72 |
| Pfizer | 5 | $68 |
| Cardiva Medical, Inc. | 1 | $29 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
| Amgen | 1 | $14 |
| Alnylam Pharmaceuticals Inc. | 1 | $13 |
| Merck | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Reveal LINQ$1,144
- Barostim Neo System$1,051
- AVEIR$818
- BioMonitor$298
- Edora 8 DR-T$298
- Solia$298
- Acticor 7 VR-T DX$298
- Rivacor 7 DR-T$298
- Micra$235
- SelectSecure$173
- Carto 3 System$116
- Carto 3$112
- QDOT MICRO$102
- CareLink$100
How this compares
$16,460 in reported general payments places this provider in the 30th percentile of 29 clinical cardiac electrophysiology providers in Utah.
See all clinical cardiac electrophysiology providers in Utah →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 150 | $137,220 |
| XareltoRivaroxaban | 13 | $14,019 |
| Dabigatran EtexilateDabigatran Etexilate Mesylate | 18 | $3,233 |
| Flecainide Acetate | 59 | $2,010 |
| Mexiletine Hcl | 26 | $1,449 |
| Colchicine | 33 | $837 |
| Metoprolol Succinate | 42 | $696 |
| Propafenone Hcl | 12 | $687 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 23 | $570 |
| Metoprolol Tartrate | 38 | $516 |
| SotalolSotalol Hcl | 26 | $292 |
| Amiodarone Hcl | 12 | $247 |
| Amlodipine Besylate | 19 | $193 |
| Pyridostigmine Bromide | 11 | $164 |
| Propranolol Hcl ErPropranolol Hcl | 12 | $129 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $68 | $137,220150 claims |
| Johnson & JohnsonXarelto | $135 | $14,01913 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 30th percentile of 29 clinical cardiac electrophysiology providers in Utah.
Other clinical cardiac electrophysiology in St. George
- Ravi RanjanSalt Lake City$345K
- John DaySalt Lake City$313K
- Chun HwangProvo$289K
- Roger FreedmanSalt Lake City$177K
- Douglas PackerMurray$169K
- Sandeep TalwarFarmington$82K
- Michael CutlerMurray$70K
- Nischala NannapaneniSalt Lake City$57K
- Weston HarknessSt George$49K
- Helge LehmannSalt Lake City$49K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.